Biogen stock climbs on drug approval recommendation, Oracle shares rise ahead of earnings, and other stocks on the move


Here are some of the biggest movers of Monday.

Stock gainers:

Biogen Inc. shares

rallied 5% following a full-day halt during the regular session as a Food and Drug Administration committee convened to vote on an approval recommendation for the biotech’s Alzheimer’s drug candidate it makes with Eisai Co.

The committee voted unanimously to recommend approval, and Biogen shares took off when they were unhalted.


Source link